NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype

Archive ouverte

Pasmant, Eric | Sabbagh, Audrey | Spurlock, Gill | Laurendeau, Ingrid | Grillo, Elisa | Hamel, Marie-Josée | Martin, Ludovic | Barbarot, Sébastien | Leheup, Bruno | Rodriguez, Diana | Lacombe, Didier | Dolfus, Helene | Pasquier, Laurent | Isidor, Bertrand | Ferkal, Salah | Soulier, Jean | Sanson, Marc | Dieux-Coeslier, Anne | Bieche, Ivan | Parfait, Béatrice | Vidaud, Michel | Wolkenstein, Pierre | Upadhyaya, Meena | Vidaud, Dominique

Edité par CCSD ; Wiley -

International audience. In 5-10% of patients, neurofibromatosis type 1 (NF1) results from microdeletions that encompass the entire NF1 gene and a variable number of flanking genes. Two recurrent microdeletion types are found in most cases, with microdeletion breakpoints located in paralogous regions flanking NF1 (proximal NF1-REP-a and distal NF1-REP–c for the 1.4 Mb type-1 microdeletion, and SUZ12 and SUZ12P for the 1.2 Mb type-2 microdeletion). A more severe phenotype is usually associated with NF1 microdeletion patients than in those with intragenic mutations. We characterized NF1 microdeletions in 70 unrelated NF1 microdeleted patients using a high-resolution NF1 custom array comparative genomic hybridization (CGH). Genotype-phenotype correlations were studied in 58 of these microdeletion patients and compared to 389 patients with intragenic truncating NF1 mutations and phenotyped in the same standardized way. Our results confirmed in an unbiased manner the existence of a contiguous gene syndrome with a significantly higher incidence of learning disabilities and facial dysmorphism in microdeleted patients compared to patients with intragenic NF1 mutations. Microdeleted NF1 patients also showed a trend toward significance for childhood overgrowth. High-resolution array-CGH identified a new recurrent ~1.0 Mb microdeletion type, designated as type-3, with breakpoints in the paralogous regions middle NF1-REP-b and distal NF1-REP–c.

Suggestions

Du même auteur

Modifier genes in NF1: results of the first Genome-Wide Association Study in 1,333 patients

Archive ouverte | Ferkal, Salah | CCSD

International audience

Identification of potential common genetic modifiers of neurofibromas: a genome wide association study in 1,333 neurofibromatosis type 1 patients

Archive ouverte | Pacot, Laurence | CCSD

International audience. BackgroundNeurofibromatosis type 1 (NF1) is characterized by the highly variable and unpredictable development of benign peripheral nerve sheath tumours: cutaneous (cNFs), subcutaneous (scNFs...

Severe phenotype in patients with large deletions of NF1

Archive ouverte | Pacot, Laurence | CCSD

International audience. Complete deletion of the NF1 gene is identified in 5–10% of patients with neurofibromatosis type 1 (NF1). Several studies have previously described particularly severe forms of the disease in...

Chargement des enrichissements...